Zhejiang Kanglaite Pharmaceutical Co., Ltd. is a ?ate Key High-tech Enterprise entitled by China Ministry of Science & Technology. Covering an area of 7 hectares and a total floor space of 28,000 sq. m, the LVP production line and auxiliary equipment were totally introduced from Europe and USA. International GMP standard is strictly followed in production. There are over 500 staff of whom 60% are with university diploma. And 32 regional offices in China offer a strong momentum in expanding domestic market. 



As "State Basic Drug" and "State Medical Insurance Drug", Kanglaite Injection (KLT) is a novel dual-function, broad spectrum and molecular targeting anticancer agent with its active substance extracted from a medicinal herb "semen coicis" by state of the art technology. KLT has remarkable function in inhibiting and killing...